However, while these studies have provided significant insights into the processes impacted by impaired IR activity in the brain (a phenomenon strongly implicated in the progression of pathological aging and AD), they do not directly report on the potential mechanisms targeted by exogenous insulin. This evidence concerns the gene INS and Alzheimer disease.